EuroPCR coverage 2

EuroPCR coverage 2

This is MATRIX time @ EuroPCR 2016.

I had the privilege of presenting one of the most important subsidies of the Matrix trial, PI Marco Valgimigli, assessing the role of transradial vs. transfemoral PCI either in STEMI or NSTE-ACS patients undergoing invasive management.

Results were consistent with the main publication in Lancet last year, showing a significant benefit in terms of NACE and a strong trend in terms of improvement of MACE for the transradial approach.

EuroPCR coverage 1

EuroPCR coverage 1

This is the official TCTMD report on the late-breaking clinical trial session on BVS at the latest EuroPCR.

I am proud of being part of it, presenting the short-term data of the RAI registry. And I am also proud that our centre was the second top enroller centre in both the RAI and IT-DISAPPEARS registry!

http://www.tctmd.com/show.aspx?id=135200

Bivalirudin use-an update after the Matrix trial

Bivalirudin use-an update after the Matrix trial

This is the presentation I had at the CCIF meeting at Guiyang, China, April 2015.

Which is the current role of Bivalirudin in ACS patients, nowadays? Did the Matrix trial change the scenario, or created more confusion on the matter?

 

FinalBivalirudin presentation China

Recent Faculty at international/national meetings (since 2010)

Congresso della Società di Cardiologia Interventistica Italiana (GISE) Genova October 2015
CCIF, China Cardiovascular Meeting, Hong King, April 2015
Abbott Absorb BVS Advisory Board, Milano March 2015
GISE TOLOVE Clinical Interventional Forum, Bologna, January 2015
IV DEB School, Milan, January 2015
Meeting scientifico Ospedale Monaldi, Napoli Dicembre 2014
Breaking news in interventistica cardiovascolare, Milano Novembre 2014
GISE TOLOVE Clinical Interventional Forum, Venezia, November 2014
AIM RADIAL, Chicago, October 2014
Congresso della Società di Cardiologia Interventistica Italiana (GISE) Genova October 2014
MILAN HEMODYNAMICS MEETING, October 2014
FATEBENEFRATELLI INTERNAL MEETING, September 2014
GISE TOLOVE Clinical Interventional Forum, Grosseto, September 2014
FIRST INTERNATIONAL LIVE DCB COURSE, Milano May 2014 (Course Promoter, Director and Organizer)
Trinations, Cagliari June 2014
GISE TOLOVE Clinical Interventional Forum, Gardone, May 2014
DEB School III, Milan, February 2014 (Course Director)
Rumors about innovations, Milano December 2013
TCT 2013 (San Francisco, October 2013): International Faculty
Congresso della Società Italiana di Cardiologia (GISE), Genova Ottobre 2013
Indian College of Cardiology Conference 2013 (ICCAD 13) & IECR, Trivandrum, Kerala, India, September 2013
GISE Lombardia Clinical Interventional Forum, Stresa, September 2013
DEB School II, Milan, June 2013 (Course Director)
EuroPCR 2013, Paris, France, May 2013
GISE-ANMCO Clinical Interventional Forum, Lido di Camaiore, May 2013
SEIC, Berlin, Germany, April 2013
DEB School I, Milan, April 2013 (Course Director)
GISE-ANMCO Clinical Interventional Forum, Lazise (VR), April 2013
VII Indo-European Course on Revascularization, Basil, CH 2013 (Course co-director)
CRT meeting, Washington DC January 2013
V Endotask Symposium, Bergamo October 2012
Congresso della Società Italiana di Cardiologia (GISE), Genova Ottobre 2012
TRI NATIONS, Radial workgroup, Turin, 19-29 April 2012
CHARING CROSS Peripheral meeting, London, 14-17 April 2012
LINC Leipzig Course on revascularization, Leipzig, Germany, January 2012
CRT, Washington, US, February 2012 (Young Leader)
MEET meeting, Rome, December 2011
Clinical Interventional Forum, GISE Lombardia, Milan, November 2011
VI Indo-European Course on Revascularization, Rome, Italy November 2011 (Course co-director)
Congresso della Società Italiana di Cardiologia (GISE), Genova Ottobre 2011
IV Endotask Symposium, Bergamo October 7-8 2011
Young for…lux, Zerman di Mogliano Veneto, March 2011. Biotronik sponsored meeting
V Indo-European Course on Revascularization, New Dehli, India January 2011 (recorded presentation)
La vasculopatia diabetica polidistrettuale, Clinica Sant’Ambrogio, Milano, 27.11.2010.
Balloon Angioplasty reborn, local drug delivery to treat coronary and arterial occlusive disease, Berlin, October 2010
Congresso della Società Italiana di Cardiologia (GISE), Genova Ottobre 2010
IV Indo-European Course on Revascularization, Amsterdam, August 2010
the role of BVS in 2015

the role of BVS in 2015

The most widely used Biovascular Scaffold worldwide, namely Absorb, Abbott, is a real revolution in interventional cardiology. A lot of things changed after BVS became available, however we learned that, most importantly, the approach to PCI did change as well: like for DCB-PCI, it is not just like to implant a stent here!

This is the presentation I made at Stresa, a national meeting organized by AS Bongo, Novara Hospital, in May 2015.

Cortese for website